From the magazine LSR 4/2019 | S. 248-253 The following page is 248

Product Regulation

Marketing of CBD Products in Switzerland

Overview of the Complex Regulatory Framework

I. Preliminary Remarks

In Switzerland, a liberal regulation applies to products with a low tetrahydrocannabinol (THC) content. Whereas cannabis products with 1% or more content of THC are considered as a controlled substance, cannabidiol (CBD) is generally marketable since it is not included in any narcotics regulation.1 With a revision of the respective ordinance on 30 May 2011, the permissible THC content of cannabis products was increased from 0.3% to 1%.2 This revision made it possible to cultivate and market products containing CBD. Flowers intended for smoking and containing a high proportion of CBD and less than 1% THC can be legally sold and purchased.3 Compared to other surrounding countries,4 this is a very liberal regulation, which led to a lively trade in such products.5

Raw material or products with a THC of 1% or more are considered as a controlled substance in Switzerland.6 This could change to some part in the near future: The Federal Council recently initiated a…

[…]
Melden Sie sich für den LSR-Newsletter an und bleiben Sie informiert.